Picton Mahoney Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Picton Mahoney Asset Management’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-370,000	Closed	-$17.2M	–	532
2023 Q2	$17.2M	Buy	+370,000	New	+$12.8M	0.74%	26

Picton Mahoney Asset Management's DICE Position: Q3 2023 in Review

Picton Mahoney Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 370,000 shares — an estimated $17.2M sold.

Picton Mahoney Asset Management first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $17.2M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Picton Mahoney Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Picton Mahoney Asset Management sold 370,000 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $17.2M.
Picton Mahoney Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Picton Mahoney Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $17.2M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Picton Mahoney Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.